# Recursion (RXRX) — News

RXRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rxrx/news

## Recent headlines

- [Recursion Pharmaceuticals - Candidate added to Sanofi pipeline, phase 1 trials expected in 2027](https://www.ainvest.com/news/recursion-pharmaceuticals-candidate-added-sanofi-pipeline-phase-1-trials-expected-2027-2610) — AInvest Wire, Oct 15, 2026
  Recursion Pharmaceuticals, Inc. has announced that one of its drug candidates has been added to Sanofi’s development pipeline, marking a strategic collaboration between the two biopharmaceutical companies. The candidate, which is currently in preclinical development, is expected to enter Phase 1…
- [Recursion Pharmaceuticals - Eligible for over $300 mln in additional milestones and double digit royalties](https://www.ainvest.com/news/recursion-pharmaceuticals-eligible-300-mln-additional-milestones-double-digit-royalties-2610) — AInvest Wire, Oct 15, 2026
- [Recursion Pharmaceuticals - Receives $10 mln milestone payment, total payments now $144 mln](https://www.ainvest.com/news/recursion-pharmaceuticals-receives-10-mln-milestone-payment-total-payments-144-mln-2610) — AInvest Wire, Oct 15, 2026
- [Recursion announces Sanofi options potential first-in-class immunology development candidate from their collaboration](https://www.ainvest.com/news/recursion-announces-sanofi-options-potential-class-immunology-development-candidate-collaboration-2610) — AInvest Wire, Oct 15, 2026
- [Recursion Pharmaceuticals - Prices underwritten offering of 61,540,000 class A shares at $3.25 per share](https://www.ainvest.com/news/recursion-pharmaceuticals-prices-underwritten-offering-61-540-000-class-shares-3-25-share-2610) — AInvest Wire, Oct 15, 2026
  Recursion Pharmaceuticals, Inc. (RXRX) has announced the pricing of an underwritten offering of 61,540,000 Class A shares at $3.25 per share. The offering is part of the company’s ongoing efforts to raise capital to support its operations and research initiatives. The total gross proceeds from the…

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).